Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 10:24 am Purchase | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | MACQUARIE GROUP LTD | 3,767,892 6.150% | 1,003,970 (+36.32%) | Filing History |
| 2022-02-14 09:01 am Sale | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 2,450,000 4.000% | -640,200 (-20.72%) | Filing History |
| 2022-02-10 5:22 pm Sale | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | JANUS HENDERSON GROUP PLC JHG | 4,016,158 6.600% | -67,395 (-1.65%) | Filing History |
| 2022-02-10 11:11 am Sale | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,302,492 2.130% | -1,547,508 (-54.30%) | Filing History |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | VANGUARD GROUP INC | 3,880,873 6.340% | 476,430 (+13.99%) | Filing History |
| 2022-02-02 7:18 pm Sale | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | BlackRock Inc. BLK | 4,515,145 7.400% | -310,029 (-6.43%) | Filing History |
| 2022-02-01 2:44 pm Purchase | 2021-12-31 | 13G | TRAVERE THERAPEUTICS INC TVTX | GOLDMAN SACHS GROUP INC GS | 4,599,279 7.500% | 3,902,427 (+560.01%) | Filing History |
| 2021-08-13 4:27 pm Purchase | 2021-08-04 | 13G | TRAVERE THERAPEUTICS INC TVTX | Deep Track Capital LP | 3,090,200 5.090% | 3,090,200 (New Position) | Filing History |